{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:02:33Z","timestamp":1790827353963,"version":"4.1.0"},"reference-count":73,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2025,3,4]]},"DOI":"10.1080\/14740338.2024.2446405","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T16:28:09Z","timestamp":1735057689000},"page":"251-259","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Safety of current treatments for advanced cholangiocarcinoma"],"prefix":"10.1080","volume":"24","author":[{"given":"Tiago Biachi","family":"de Castria","sequence":"first","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute","place":["Tampa, USA"]},{"name":"University of South Florida","place":["Tampa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Kim","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute","place":["Tampa, USA"]},{"name":"University of South Florida","place":["Tampa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj234"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.25087"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0446"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33476"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2015.49004"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-1939-4"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071970"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.3_suppl.231"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605211"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604628"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.07.041"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.05.018"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00027-9"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200015"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00727-4"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.085"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00082-2"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14093"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3375"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31092"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0095-6"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1077"},{"key":"e_1_3_3_26_1","unstructured":"ClinicalTrials.gov [Internet]. Identifier NCT05921760 ivosidenib nivolumab and ipilimumab combination in Previously treated subjects with nonresectable or metastatic IDH1 mutant cholangiocarcinoma. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05921760"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01761-7"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.3606"},{"key":"e_1_3_3_29_1","unstructured":"ClinicalTrials.gov [Internet]. Identifier NCT04601857 futibatinib and pembrolizumab combination in the treatment of advanced or metastatic urothelial carcinoma. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04601857"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01440"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.001"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3064"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06480-5"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.58"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.01.033"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0726"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30109-1"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy424.030"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206834"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.44"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103091"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006023.pub3"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22627"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.0500"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.8034"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2023.09.007"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1645-y"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00196-5"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.02.001"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2008.03.028"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817323"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0697"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.3331"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30157-1"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.3836"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00336-3"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00242-5"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00606"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00335-1"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.4006"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-016-9645-x"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1159\/000511919"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113564"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0000000000000637"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.05.011"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030713"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102113"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00679"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.4_suppl.LBA490"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.080"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/annonc\/annonc1089"},{"key":"e_1_3_3_72_1","unstructured":"Biosyngen announces FDA fast track designation for BST02 in treatment of liver cancer. News release. Biosyngen; 2024 Feb 1 [cited 2024 Feb 1]. Available from: https:\/\/www.prnewswire.com\/news-releases\/biosyngen-announces-fda-fast-track-designation-for-bst02-in-treatment-of-liver-cancer-302050377.html"},{"key":"e_1_3_3_73_1","unstructured":"ClinicalTrials.gov [Internet]. Identifier NCT06173726 investigator-initiated phase I exploratory clinical study of the safety tolerability and efficacy of BST-2 injection in the treatment of locally advanced\/metastatic liver cancer. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT06173726"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092854"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49860-0"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2446405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T20:03:37Z","timestamp":1741896217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2446405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,4]]}},"alternative-id":["10.1080\/14740338.2024.2446405"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2446405","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}